{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:36:29Z","timestamp":1780598189573,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.atherosclerosis.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T17:01:36Z","timestamp":1347987696000},"page":"291-295","source":"Crossref","is-referenced-by-count":43,"title":["Omega-3 fatty acids: Benefits for cardio-cerebro-vascular diseases"],"prefix":"10.1016","volume":"225","author":[{"given":"G.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ermilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000229786","article-title":"Reduction of arteriosclerotic nanoplaque formation and size by n-3 fatty acids in patients after valvular defect operation","volume":"16","author":"Koppe","year":"2009","journal-title":"Forsch Komplementmed"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM199704103361502","article-title":"Fish consumption and the 30-year risk of fatal myocardial infarction","volume":"336","author":"Daviglus","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","author":"Gissi-Prevenzione Investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib5","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.CIR.0000069566.78305.33","article-title":"Clinical prevention of sudden cardiac death by omega-3 polyunsaturated fatty acids and mechanisms of prevention of arrhythmias by omega-3 fish oils","volume":"107","author":"Leaf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(03)12468-3","article-title":"Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial","volume":"361","author":"Thies","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib7","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"N\u20133 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/01.ATV.20.8.1990","article-title":"ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype","volume":"20","author":"Minihane","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-130-7-199904060-00003","article-title":"The effect of dietary \u03c9-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial","volume":"130","author":"Von Schacky","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.CIR.103.5.651","article-title":"Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography","volume":"103","author":"Christensen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0753-3322(02)00256-1","article-title":"Polyunsaturated fatty acids and inflammatory diseases","volume":"56","author":"Gil","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S0100-879X2003000400004","article-title":"Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients","volume":"36","author":"Calder","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1179\/rer.2000.5.1.45","article-title":"Effect of \u03c93 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion","volume":"5","author":"Mori","year":"2000","journal-title":"Redox Rep"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcn\/74.4.449","article-title":"Moderate intake of n\u20133 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects","volume":"74","author":"Mabile","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9149(99)80130-1","article-title":"Comparison of effects of n-3 to n-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease","volume":"76","author":"Herrmann","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.V10102177","article-title":"Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in\u00a0vivo peroxidation of LDL in dialysis patients","volume":"10","author":"Ando","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib17","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.287.14.1815","article-title":"Fish and omega-3 fatty acid intake and risk of coronary heart disease in women","volume":"287","author":"Hu","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","article-title":"Blood levels of long-chain n-3 fatty acids and the risk of sudden death","volume":"346","author":"Albert","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198602203140806","article-title":"The pathogenesis of atherosclerosis \u2013 an update","volume":"314","author":"Ross","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis: the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ejhg.5200290","article-title":"Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians","volume":"7","author":"Scholz","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9149(01)02257-3","article-title":"Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia","volume":"89","author":"Sasaki","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.ATV.18.6.984","article-title":"Dominant negative effect of TGF-\u03b21 and TNF-\u03b1 on basal and IL-6\u2013induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures","volume":"18","author":"Ramharack","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib25","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2005.05.031","article-title":"Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation. Task Force on clinical expert consensus documents","volume":"46","author":"Vogel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib27","doi-asserted-by":"crossref","first-page":"1477S","DOI":"10.1093\/ajcn\/83.6.1477S","article-title":"n\u20133 fatty acids and cardiovascular disease","volume":"83","author":"Breslow","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib28","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease. Effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1194\/jlr.M002667","article-title":"Reduced prostaglandin F2\u03b1 release from blood mononuclear leukocytes after oral supplementation of \u03c93 fatty acids: the OmegAD study","volume":"51","author":"Vedin","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib30","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/bmj.328.7430.30","article-title":"Omega 3 fatty acids and cardiovascular disease \u2013 fishing for a natural treatment","volume":"328","author":"Din","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archinte.165.7.725","article-title":"Effect of different antilipidemic agents and diets on mortality. A systematic review","volume":"165","author":"Studer","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","article-title":"Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review","volume":"332","author":"Hooper","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.STR.25.2.328","article-title":"Fish consumption and risk of stroke. The Zutphen study","volume":"25","author":"Keli","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archinte.1996.00440050091010","article-title":"The relationship between fish consumption and stroke incidence. The NHANES I epidemiologic follow-up study","volume":"156","author":"Gillum","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.STR.27.2.204","article-title":"Fish consumption and stroke in men. 30-Year findings of the Chicago Western Electric study","volume":"27","author":"Orencia","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib37","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/01.STR.0000023890.25066.50","article-title":"Linoleic acid, other fatty acids, and the risk of stroke","volume":"33","author":"Iso","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.325.7370.932","article-title":"Fish, meat, and risk of dementia: cohort study","volume":"325","author":"Barberger-Gateau","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib40","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.0000130856.31468.47","article-title":"Fish consumption and incidence of stroke. A meta-analysis of cohort studies","volume":"35","author":"He","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib41","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/STROKEAHA.107.505776","article-title":"Large artery intracranial occlusive disease. A large worldwide burden but a relatively neglected frontier","volume":"39","author":"Gorelick","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archinte.166.13.1403","article-title":"Healthy lifestyle and the risk of stroke in women","volume":"166","author":"Kurth","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib43","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/STROKEAHA.107.509455","article-title":"For the JELIS Investigators, Japan. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients. Subanalysis of the JELIS trial","volume":"39","author":"Tanaka","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib44","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/STROKEAHA.111.620856","article-title":"Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage","volume":"42","author":"Lalancette-H\u00e9bert","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2011.12.043","article-title":"Dietary fats and dietary cholesterol and risk of stroke in women","volume":"221","author":"Larsson","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2012.09.006_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2012.09.007","article-title":"Plasma phospholipid fatty acid composition in ischemic stroke: importance of docosahexaenoic acid in the risk for intracranial artery stenosis","volume":"225","author":"Kim","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCULATIONAHA.105.578229","article-title":"For the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis","volume":"113","author":"Kasner","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plefa.2010.02.006","article-title":"Polyunsaturated fatty acids, neuroinflammation and well being","volume":"82","author":"Lay\u00e9","year":"2010","journal-title":"Prostaglandins, Leukot Essent Fatty Acids"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib49","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1073\/pnas.0502903102","article-title":"Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival","volume":"102","author":"Akbar","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib50","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.410420514","article-title":"Dietary fat intake and the risk of incident dementia in the Rotterdam study","volume":"42","author":"Kalmijn","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease. The Framingham Heart Study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib53","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archneur.62.12.noc50161","article-title":"Fish consumption and cognitive decline with age in a large community study","volume":"62","author":"Morris","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib54","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"\u03c9-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study. A randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gps.1857","article-title":"Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms","volume":"23","author":"Freund-Levi","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib56","unstructured":"Siegel G, Malmsten M. Molecular model for athero\/arteriosclerosis. Patent EP 0 946 876; 2005."},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0008-6363(03)00249-9","article-title":"Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model","volume":"58","author":"Siegel","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2007.02.021","article-title":"Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients","volume":"192","author":"Rodr\u00edguez","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib59","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bios.2008.08.011","article-title":"Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profile","volume":"24","author":"Siegel","year":"2009","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib60","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","article-title":"Brain to plasma amyloid-\u03b2 efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"295","author":"DeMattos","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib62","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma A\u03b242\/A\u03b240 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib63","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid \u03b2 peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","article-title":"Apolipoprotein E associates with \u03b2 amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3","volume":"94","author":"Sanan","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib65","first-page":"414","article-title":"Heparan sulfate proteoglycan\/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease","volume":"32","author":"Mahley","year":"1996","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcis.2004.05.044","article-title":"An ellipsometry-based Alzheimer plaque mimic: effect of \u03b2-amyloid, lipoprotein identity and apolipoprotein E isoform","volume":"276","author":"Malmsten","year":"2004","journal-title":"J\u00a0Colloid Interface Sci"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","article-title":"Competition of A\u03b2 amyloid peptide and apolipoprotein E for receptor-mediated endocytosis","volume":"40","author":"Winkler","year":"1999","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.09.006_bib68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","article-title":"Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. A systematic review and meta-analysis","volume":"308","author":"Rizos","year":"2012","journal-title":"JAMA"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012006193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012006193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:10:43Z","timestamp":1643451043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012006193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0021915012006193"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.09.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}